Harison C. Hong, MD, MBA

Harison C. Hong, MD, MBA is a Global Commercial Lead for Atopic Dermatitis, Nemolizumab at Galderma.13 He is a decisive and strategic leader passionate about improving patient healthcare outcomes.1 Dr. Hong has over 12 years of experience in clinical practice and healthcare, specializing in Nuclear Medicine.

Prior to his current role at Galderma, Dr. Hong worked at Sanofi for 9 years, celebrating his anniversary there in August 2023.2 He has been involved in various aspects of healthcare, including:

1. Presenting pivotal data on chronic spontaneous urticaria management at the AAAAI conference in 2022.6
2. Participating in dermatology events, such as the Aesthetic Dermatology Medical Academic Scientific Congress (ADermaMAS) in 2024.4

Dr. Hong's LinkedIn profile (username: harison-c-hong) showcases his professional journey and insights in the healthcare industry.123 He has shared thoughts on leadership, emphasizing the differences between coaches, mentors, and sponsors.5